Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 3
1989 1
1990 3
1991 3
1994 6
1995 4
1996 1
1997 2
1999 1
2001 1
2002 2
2003 1
2004 2
2005 1
2006 1
2007 3
2008 4
2009 13
2010 8
2011 3
2012 3
2013 3
2014 8
2015 12
2016 13
2017 9
2018 13
2019 16
2020 16
2021 13
2022 15
2023 18
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Results by year

Filters applied: . Clear all
Page 1
Preface.
Gallegos C, Ruiz-Méndez MV. Gallegos C, et al. Adv Food Nutr Res. 2023;105:xi-xii. doi: 10.1016/S1043-4526(23)00046-3. Adv Food Nutr Res. 2023. PMID: 37516470 No abstract available.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy.
Gillmore JD, Judge DP, Cappelli F, Fontana M, Garcia-Pavia P, Gibbs S, Grogan M, Hanna M, Hoffman J, Masri A, Maurer MS, Nativi-Nicolau J, Obici L, Poulsen SH, Rockhold F, Shah KB, Soman P, Garg J, Chiswell K, Xu H, Cao X, Lystig T, Sinha U, Fox JC; ATTRibute-CM Investigators. Gillmore JD, et al. N Engl J Med. 2024 Jan 11;390(2):132-142. doi: 10.1056/NEJMoa2305434. N Engl J Med. 2024. PMID: 38197816 Clinical Trial.
Rheological Issues on Oropharyngeal Dysphagia.
Gallegos C, Turcanu M, Assegehegn G, Brito-de la Fuente E. Gallegos C, et al. Dysphagia. 2023 Apr;38(2):558-585. doi: 10.1007/s00455-021-10337-w. Epub 2021 Jul 3. Dysphagia. 2023. PMID: 34216239 Review.
Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD): A Systematic Review.
Aguirre AS, Astudillo Moncayo OM, Mosquera J, Muyolema Arce VE, Gallegos C, Ortiz JF, Andrade AF, Oña S, Buj MJ. Aguirre AS, et al. Among authors: gallegos c. Cureus. 2023 Jun 3;15(6):e39903. doi: 10.7759/cureus.39903. eCollection 2023 Jun. Cureus. 2023. PMID: 37404420 Free PMC article. Review.
Nutritional Aspects of Dysphagia Management.
Gallegos C, Brito-de la Fuente E, Clavé P, Costa A, Assegehegn G. Gallegos C, et al. Adv Food Nutr Res. 2017;81:271-318. doi: 10.1016/bs.afnr.2016.11.008. Epub 2016 Dec 23. Adv Food Nutr Res. 2017. PMID: 28317607 Review.
The authors reply.
Gallegos C, Tobolowsky F, Nigo M, Hasbun R. Gallegos C, et al. Crit Care Med. 2019 Feb;47(2):e155. doi: 10.1097/CCM.0000000000003532. Crit Care Med. 2019. PMID: 30653072 No abstract available.
Higher-Dose Fluvoxamine and Time to Sustained Recovery in Outpatients With COVID-19: The ACTIV-6 Randomized Clinical Trial.
Stewart TG, Rebolledo PA, Mourad A, Lindsell CJ, Boulware DR, McCarthy MW, Thicklin F, Garcia Del Sol IT, Bramante CT, Lenert LA, Lim S, Williamson JC, Cardona OQ, Scott J, Schwasinger-Schmidt T, Ginde AA, Castro M, Jayaweera D, Sulkowski M, Gentile N, McTigue K, Felker GM, DeLong A, Wilder R, Rothman RL, Collins S, Dunsmore SE, Adam SJ, Hanna GJ, Shenkman E, Hernandez AF, Naggie S; Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-6 Study Group and Investigators. Stewart TG, et al. JAMA. 2023 Dec 26;330(24):2354-2363. doi: 10.1001/jama.2023.23363. JAMA. 2023. PMID: 37976072
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Lancet Reg Health Eur. 2023 Sep 19;34:100736. doi: 10.1016/j.lanepe.2023.100736. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37753216 Free PMC article.
182 results